Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. (2021)
Attributed to:
Psychosis Immune Mechanism Stratified Medicine Study (PIMS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.70296
Publication URI: https://www.repository.cam.ac.uk/handle/1810/322840
Type: Journal Article/Review